Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126258831 | 12625883 | 1 | I | 20160427 | 20160805 | 20160805 | PER | US-ABBVIE-16P-163-1619555-00 | ABBVIE | 0.00 | M | Y | 95.25000 | KG | 20160805 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126258831 | 12625883 | 1 | PS | VIEKIRA PAK | DASABUVIROMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | U | UNKNOWN | 206619 | TABLET | ||||||||
| 126258831 | 12625883 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126258831 | 12625883 | 1 | Hepatitis C |
| 126258831 | 12625883 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126258831 | 12625883 | Blood bilirubin increased | |
| 126258831 | 12625883 | Irregular sleep phase | |
| 126258831 | 12625883 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |